Dr. Carr is the Design and Oversight Team Lead for the Clinical Research Branch in the Division of Tuberculosis Elimination within the National Center for HIV, Viral Hepatitis, STD and TB Prevention at the Centers for Disease Control and Prevention (CDC), where she supports the success of clinical trials conducted by the Tuberculosis Trials Consortium (TBTC), which has been conducting programmatically relevant clinical research concerning the diagnosis, clinical management, treatment and prevention of tuberculosis infection and disease for more than two decades.
Dr. Carr has more than 15 years of experience in clinical trials and human subjects protection, including serving as the Regulatory Oversight Team Lead for the STRIVE trial (Sierra Leone Trial to Introduce a Vaccine against Ebola), where she was responsible for diverse aspects of trial implementation, regulatory guidance and interpretation for clinical trial operations. At CDC, she has also served in the Advisory Committee on Immunization Practices (ACIP) secretariat focused on the use of evidence-based methodology for developing public health recommendations, as a Human Subjects Advisor serving as a resource and guide to investigators on regulations pertaining to human subjects protection, and as a Scientific Review Officer providing oversight of the peer review of research grants and cooperative agreements. Prior to CDC, Wendy worked as a Regulatory Affairs Specialist at NIH/DMID providing leadership, oversight, management, and scientific regulatory expertise in the planning and implementation of clinical research studies involving vaccines for early stage, phase I, and phase II clinical trials, after spending 6 years in the Division of Bacterial, Parasitic, and Allergenic Products at FDA/CBER.
She earned a BS in Biochemistry from the Florida State University, a PhD in Microbiology and Molecular Genetics from Emory University, and has held the Certified IRB Professional (CIP) credential since 2014.